Connection

Diane Kamen to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Diane Kamen has written about Antibodies, Monoclonal, Humanized.
Diane Kamen
Connection Strength
0.287
Antibodies, Monoclonal, Humanized
  1. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Arthritis Rheumatol. 2021 01; 73(1):121-131.
    View in: PubMed
    Score: 0.168
  2. Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices. J Rheumatol. 2015 Dec; 42(12):2288-95.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.